Proven Executive Sales Specialist Seeking Leadership Position
Dynamic individual with hands-on experience in pharmaceutical sales and talent for navigating challenges. Brings strong problem-solving skills and proactive approach to new tasks. Known for adaptability, creativity, and results-oriented mindset. Committed to making meaningful contributions and advancing organizational goals.
Co-Chair of AMP Peer Learning
Attended and taught parts of Tier 2 training as an FST
intrim DM for MYM 2024 (included attending DM prep meeting for MYM 2024)
Mentoring peers on my team and across the country
Voted as ICON At Alcon Award winner at MYM 2024
Collaboration with MSLs was used as example nationally
Virtual FST for onboarding with new Albany Sales Specialist
2023
Responsible for selling and growing Rocklatan, Rhopressa, Simbrinza, and Eysuvis
Co-Chair of AMP Peer Learning
2023 President’s Club Winner (Ranked #10/107)
Mentored, rode with, provided feedback to two peer sales specialists
2021-2022
Responsible for relaunching the legacy of Alcon Pharmaceuticals with Simbrinza, Eysuvis, Systane, Pataday
Grew all products to be at or over 100% AVQ
Finished #2 in nation with Eysuvis at 164% AVQ
Q3 2022 QSEA winner and 2022 Circle of Excellence winner
Demonstrated experience with primary care, internal medicine, psychiatrists, cardiologists, neurologists, and gastroenterologists. Disease states covering depression, schizophrenia, bi-polar, hypertension, dementia/Alzheimers, fibromyalgia, constipation, irritable bowel, and dry eye.
Successfully launched seven drug therapies (Viibryd, Linzess, Fetzima, Namenda XR, Namzaric, Restasis, Viberzi)
Launched Linzess in 2013 in the top 18%, launched Fetzima in 2014 top 25%, launched Restasis in 2015 Finished #1 in the nation for Saphris in Q1 2015 at 169% to goal. All five products (Viibryd, Fetzima, Bystolic, Saphris, and Namenda XR) top 25% nationally for Q1 2015.
Rep of Quarter award for Q1 2015
Responsible for obtaining first script of Viberzi (IBS D) during week of 12/18 which contributed to our team obtaining a top 14% national ranking for first week of launch
Successfully launched Uloric for the treatment of gout, surpassing district, region and national averages. Grew territory prescription base by 480% over an 8 month period.
Consistently remained above national averages for Actos Family. In FY10, finished Q3 at 103.22% while nation finished at 99.18%..
Recognized by management and counterparts in the areas of leadership, teamwork, and compliance.
Responsible for covering a large, rural, two state geography selling dental implants and allograft regenerative materials.
Developed and continually worked with network of general dentists, prosthedontists, periodontists, and oral surgeons.
Finished first year at 97% of annual quota, surpassing national averages. Finished rookie year (2008) in top 10% of all new hires (out of 20) and ranked in the top 20% nationally (out of 136).
Ranked top 20% nationally upon conclusion of employment.
Left the company at 177% of annual quota for FY’07
National Top Performer award for July ‘07, June ’06, and May ’06
2006 Circle of Excellence award winner.
National Top Performer award for July ‘07 (761%), June ’06 (1667%), and May ’06 (1049%)
2006 Circle of Excellence award winner (top 1% of sales force)
Finished FY’06 at 258% of annual quota, Presidents Club winner (top 10%)
Ranked in top 5% of nationwide sales force (2006 and 2007)
Ranked in top 5% of nationwide sales force
National Top Performer award for October 2002
National Top Performer award for October 2002 (after only 3 months of working).
Torrance branch “Best of the Branch” award in FY’03 and FY’04.
2003 and 2004 President’s Club award winner (top 10% of sales force).